InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Bruno Julianne. Director active across 2 companies, notably CRISPR Therapeutics AG. Aggregated, 5 filings have been recorded. History available since 9 February 2026. The latest transaction was disclosed on 9 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Bruno Julianne is a declarant linked to CRISPR Therapeutics AG, where he is Chief Operating Officer, and to Galecto, Inc., where he is a Director. His 5 filings run from 2024-06-24 to 2026-02-12, and the sampled recent filings indicate a transaction nature of option exercise, with buy and sell amounts of 0.